| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |